Jiang Zhong Pharmaceutical Co.,Ltd (SHA:600750)

Market Cap	14.40B
Revenue (ttm)	4.35B
Net Income (ttm)	804.09M
Shares Out	622.72M
EPS (ttm)	1.27
PE Ratio	18.18
Forward PE	15.94
Dividend	1.20 (5.19%)
Ex-Dividend Date	n/a

Volume	5,658,719
Average Volume	7,236,194
Open	23.00
Previous Close	23.08
Day's Range	22.95 - 23.20
52-Week Range	18.17 - 27.43
Beta	0.27
RSI	54.89
Earnings Date	Apr 26, 2025

About SHA:600750

Jiang Zhong Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of Chinese patent medicines and health foods in Mainland China. The company offers OTC products for spleen and stomach, intestinal tract, anorectal, throat cough and asthma, supplements and minerals, and chronic diseases. It also offers health products for high-end nourishment, rehabilitation nutrition, gastrointestinal health, liver and gallbladder health, dietary nutrition, basic vitamins, personal care essential oils, and other businesses; and pr...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1969
• Employees: 4,182
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600750

Financial Performance

In 2024, SHA:600750's revenue was 4.44 billion, a decrease of -2.59% compared to the previous year's 4.55 billion. Earnings were 788.19 million, an increase of 9.67%.